196 related articles for article (PubMed ID: 21214876)
1. Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations.
Arnoldi A; Crimella C; Tenderini E; Martinuzzi A; D'Angelo MG; Musumeci O; Toscano A; Scarlato M; Fantin M; Bresolin N; Bassi MT
Clin Genet; 2012 Feb; 81(2):150-7. PubMed ID: 21214876
[TBL] [Abstract][Full Text] [Related]
2. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.
Goizet C; Boukhris A; Durr A; Beetz C; Truchetto J; Tesson C; Tsaousidou M; Forlani S; Guyant-Maréchal L; Fontaine B; Guimarães J; Isidor B; Chazouillères O; Wendum D; Grid D; Chevy F; Chinnery PF; Coutinho P; Azulay JP; Feki I; Mochel F; Wolf C; Mhiri C; Crosby A; Brice A; Stevanin G
Brain; 2009 Jun; 132(Pt 6):1589-600. PubMed ID: 19439420
[TBL] [Abstract][Full Text] [Related]
3. Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study.
Criscuolo C; Filla A; Coppola G; Rinaldi C; Carbone R; Pinto S; Wang Q; de Leva MF; Salvatore E; Banfi S; Brunetti A; Quarantelli M; Geschwind DH; Pappatà S; De Michele G
J Neurol; 2009 Aug; 256(8):1252-7. PubMed ID: 19363635
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic analysis of Taiwanese patients with hereditary spastic paraplegia type 5.
Lan MY; Yeh TH; Chang YY; Kuo HC; Sun HS; Lai SC; Lu CS
Eur J Neurol; 2015 Jan; 22(1):211-4. PubMed ID: 24641183
[TBL] [Abstract][Full Text] [Related]
5. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
Marelli C; Lamari F; Rainteau D; Lafourcade A; Banneau G; Humbert L; Monin ML; Petit E; Debs R; Castelnovo G; Ollagnon E; Lavie J; Pilliod J; Coupry I; Babin PJ; Guissart C; Benyounes I; Ullmann U; Lesca G; Thauvin-Robinet C; Labauge P; Odent S; Ewenczyk C; Wolf C; Stevanin G; Hajage D; Durr A; Goizet C; Mochel F
Brain; 2018 Jan; 141(1):72-84. PubMed ID: 29228183
[TBL] [Abstract][Full Text] [Related]
6. Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
Schöls L; Rattay TW; Martus P; Meisner C; Baets J; Fischer I; Jägle C; Fraidakis MJ; Martinuzzi A; Saute JA; Scarlato M; Antenora A; Stendel C; Höflinger P; Lourenco CM; Abreu L; Smets K; Paucar M; Deconinck T; Bis DM; Wiethoff S; Bauer P; Arnoldi A; Marques W; Jardim LB; Hauser S; Criscuolo C; Filla A; Züchner S; Bassi MT; Klopstock T; De Jonghe P; Björkhem I; Schüle R
Brain; 2017 Dec; 140(12):3112-3127. PubMed ID: 29126212
[TBL] [Abstract][Full Text] [Related]
7. White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1.
Biancheri R; Ciccolella M; Rossi A; Tessa A; Cassandrini D; Minetti C; Santorelli FM
Neuromuscul Disord; 2009 Jan; 19(1):62-5. PubMed ID: 19187859
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5.
Chou CT; Soong BW; Lin KP; Tsai YS; Jih KY; Liao YC; Lee YC
Ann Clin Transl Neurol; 2020 Apr; 7(4):486-496. PubMed ID: 32202070
[TBL] [Abstract][Full Text] [Related]
9. Exome Sequencing Reveals a Novel Homozygous Frameshift Mutation in the CYP7B1 Gene in a Japanese Patient with SPG5.
Nan H; Shimozono K; Ichinose Y; Tsuchiya M; Koh K; Hiraide M; Takiyama Y
Intern Med; 2019 Mar; 58(5):719-722. PubMed ID: 30333426
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the CYP7B1, PNPLA6 and C19orf12 genes in autosomal recessive hereditary spastic paraplegia.
Schubert SF; Hoffjan S; Dekomien G
Mol Cell Probes; 2016 Feb; 30(1):53-5. PubMed ID: 26714052
[TBL] [Abstract][Full Text] [Related]
11. Comparative modeling of 25-hydroxycholesterol-7α-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations.
Siam A; Brancale A; Simons C
J Mol Model; 2012 Feb; 18(2):441-53. PubMed ID: 21541746
[TBL] [Abstract][Full Text] [Related]
12. SPG5 and multiple sclerosis: clinical and genetic overlap?
Criscuolo C; Carbone R; Lieto M; Peluso S; Guacci A; Filla A; Quarantelli M; Lanzillo R; Morra VB; De Michele G
Acta Neurol Scand; 2016 Jun; 133(6):410-4. PubMed ID: 26370385
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia.
Schüle R; Brandt E; Karle KN; Tsaousidou M; Klebe S; Klimpe S; Auer-Grumbach M; Crosby AH; Hübner CA; Schöls L; Deufel T; Beetz C
Neurogenetics; 2009 Apr; 10(2):97-104. PubMed ID: 18855023
[TBL] [Abstract][Full Text] [Related]
14. CYP7B1: novel mutations and magnetic resonance spectroscopy abnormalities in hereditary spastic paraplegia type 5A.
Roos P; Svenstrup K; Danielsen ER; Thomsen C; Nielsen JE
Acta Neurol Scand; 2014 May; 129(5):330-4. PubMed ID: 24117163
[TBL] [Abstract][Full Text] [Related]
15. Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese.
Dong Y; Li XY; Wang XL; Xu F; Wang ZJ; Song Y; Li Q; Lin R; Wang C
Neurosci Lett; 2021 Sep; 761():136108. PubMed ID: 34256108
[TBL] [Abstract][Full Text] [Related]
16. Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48.
Pensato V; Castellotti B; Gellera C; Pareyson D; Ciano C; Nanetti L; Salsano E; Piscosquito G; Sarto E; Eoli M; Moroni I; Soliveri P; Lamperti E; Chiapparini L; Di Bella D; Taroni F; Mariotti C
Brain; 2014 Jul; 137(Pt 7):1907-20. PubMed ID: 24833714
[TBL] [Abstract][Full Text] [Related]
17. Description of clinical features and genetic analysis of one ultra-rare (SPG64) and two common forms (SPG5A and SPG15) of hereditary spastic paraplegia families.
Pashaei M; Davarzani A; Hajati R; Zamani B; Nafissi S; Larti F; Nilipour Y; Rohani M; Alavi A
J Neurogenet; 2021; 35(2):84-94. PubMed ID: 33771085
[TBL] [Abstract][Full Text] [Related]
18. Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients.
Schlipf NA; Schüle R; Klimpe S; Karle KN; Synofzik M; Schicks J; Riess O; Schöls L; Bauer P
Clin Genet; 2011 Aug; 80(2):148-60. PubMed ID: 21623769
[TBL] [Abstract][Full Text] [Related]
19. Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5.
Prestsæter S; Koht J; Lamari F; Tallaksen CME; Hoven STJ; Vigeland MD; Selmer KK; Rydning SL
J Neurol Sci; 2020 Dec; 419():117211. PubMed ID: 33160247
[TBL] [Abstract][Full Text] [Related]
20. Phenoconversion from Spastic Paraplegia to ALS/FTD Associated with
Theuriet J; Pegat A; Leblanc P; Vukusic S; Cazeneuve C; Millecamps S; Banneau G; Guillaud-Bataille M; Bernard E
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
